Viral Load Monitoring in HIV Infection

Overview

Journal Curr Infect Dis Rep

Specialty Infectious Diseases

Date 2000 Nov 30

PMID 11095829

Authors

Holodniy

Affiliations

Soon will be listed here.

Abstract

Measurement of HIV-1 viral load is now an accepted part of clinical practice for the determination of clinical prognosis and antiretroviral effectiveness in HIV infection. Consensus guidelines have been published on the appropriate use of this testing. Furthermore, recent advances in molecular technology have improved the sensitivity and reproducibility of viral load assays, and these improved assays have provided new insight into the pathogenesis of HIV disease. This article reviews new issues affecting viral load quantification, including viral subtypes, sex, compartmental differences, and other covariables.

References

. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA). AIDS. 1998; 12(4):F1-8. View

Ogg G, Jin X, Bonhoeffer S, Dunbar P, Nowak M, Monard S . Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 1998; 279(5359):2103-6. DOI: 10.1126/science.279.5359.2103. View

Donovan R, Moore E, Bush C, Markowitz N, Saravolatz L . Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients. AIDS. 1997; 11(8):1054-6. View

Luque A, Demeter L, Reichman R . Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection. J Infect Dis. 1999; 179(6):1405-9. DOI: 10.1086/314754. View

Min J, Katzenstein D . Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels. AIDS Res Hum Retroviruses. 1999; 15(1):51-5. DOI: 10.1089/088922299311709. View

Bernard N, Chernoff D, Tsoukas C . Effect of splenectomy on T-cell subsets and plasma HIV viral titers in HIV-infected patients. J Hum Virol. 1999; 1(5):338-45. View

Deeks S, Coleman R, White R, Pachl C, Schambelan M, Chernoff D . Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. J Infect Dis. 1997; 176(2):514-7. DOI: 10.1086/517278. View

Gottfredsson M, Cox G, Indridason O, de Almeida G, Heald A, Perfect J . Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization. J Infect Dis. 1999; 180(2):534-7. DOI: 10.1086/314887. View

Neumann A, Tubiana R, Calvez V, Robert C, Li T, Agut H . HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. AIDS. 1999; 13(6):677-83. DOI: 10.1097/00002030-199904160-00008. View

10.

Montaner J, Reiss P, Cooper D, Vella S, Harris M, Conway B . A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. JAMA. 1998; 279(12):930-7. DOI: 10.1001/jama.279.12.930. View

11.

Garcia F, Vidal C, Gatell J, Miro J, Cruceta A, Pumarola T . Changes in HIV-1 RNA viral load following tuberculin skin test. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(4):398-9. DOI: 10.1097/00042560-199808010-00019. View

12.

Rich J, Merriman N, Mylonakis E, Greenough T, Flanigan T, Mady B . Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med. 1999; 130(1):37-9. DOI: 10.7326/0003-4819-130-1-199901050-00007. View

13.

Palumbo P, Raskino C, Fiscus S, Pahwa S, Fowler M, Spector S . Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA. 1998; 279(10):756-61. DOI: 10.1001/jama.279.10.756. View

14.

OBrien T, Rosenberg P, Yellin F, Goedert J . Longitudinal HIV-1 RNA levels in a cohort of homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(2):155-61. DOI: 10.1097/00042560-199806010-00007. View

15.

Emery V, Atkins M, Bowen E, Clark D, Johnson M, Kidd I . Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6. J Med Virol. 1999; 57(3):278-82. DOI: 10.1002/(sici)1096-9071(199903)57:3<278::aid-jmv11>3.0.co;2-3. View

16.

Marchisio P, Esposito S, Zanchetta N, Tornaghi R, Gismondo M, Principi N . Effect of superimposed infections on viral replication in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. 1998; 17(8):755-7. DOI: 10.1097/00006454-199808000-00020. View

17.

WEISS L, Si-Mohamed A, Giral P, Castiel P, Ledur A, Blondin C . Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection. J Infect Dis. 1997; 176(6):1621-4. DOI: 10.1086/517341. View

18.

Vandamme A, Van Laethem K, Schmit J, Van Wijngaerden E, Reynders M, Debyser Z . Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood. Eur J Clin Invest. 1999; 29(5):445-52. DOI: 10.1046/j.1365-2362.1999.00462.x. View

19.

Hoffman I, Jere C, Taylor T, Munthali P, Dyer J, Wirima J . The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS. 1999; 13(4):487-94. DOI: 10.1097/00002030-199903110-00007. View

20.

CARPENTER C, Fischl M, Hammer S, Hirsch M, Jacobsen D, Katzenstein D . Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA. 1998; 280(1):78-86. DOI: 10.1001/jama.280.1.78. View